2 Day Virtual Life Science Technical Accounting Update Training Conference 2026: Master New ASUs, Reporting Complexities & AI-Driven Finance Innovation (May 20th - May 21st, 2026)

The life science industry can leverage new ASUs, AI, and digital transformation to address complex reporting and revenue recognition challenges. The market opportunities lie in adopting tailored solutions for biotech, pharma, and med-tech companies to enhance accounting operations and compliance readiness.


Dublin, Feb. 13, 2026 (GLOBE NEWSWIRE) -- The "Life Science Technical Accounting Update 2026 (May 20th - May 21st, 2026)" conference has been added to ResearchAndMarkets.com's offering.

The life science industry continues to face rapid change - new ASUs, evolving revenue models, digital transformation, and increasingly complex reporting expectations. The Life Science Technical Accounting Update 2026 is a two-day virtual conference designed to help finance and accounting teams stay ahead of these developments with guidance tailored specifically to biotech, pharma, and med-tech companies.

This program goes beyond the standards to focus on real-world application. Sessions will cover select ASUs, practical uses of AI and digital transformation in accounting operations, and the most challenging revenue recognition issues facing life science organizations

Learning Objectives:

  • Understand the latest accounting updates and ASUs most relevant to life science companies
  • Identify key timelines, implementation considerations, and factors influencing industry-specific reporting
  • Gain practical insight into applying AI and digital solutions within life science accounting and finance functions

Who Should Attend:

  • CFOs (and their staff)
  • Controllers
  • VPs of Finance
  • Financial Managers
  • Internal Auditors
  • Tax Accountants
  • Treasury Staff
  • Accountants in Industry
  • Internal Control/SOX personnel
  • Consultants
  • Public Accountants
  • Educators

Agenda:

Agenda: DAY 1

8:45-10:20 SEC & FASB Developments Affecting Life Science Companies

10:20-10:30 Break

10:30-11:45 Accounting for Convertible Debt

  • New Guidance
  • Questions to Consider
  • Accounting Models

11:45-1:00 Lunch Break

1:00-2:10 GenAI Automation Update

2:10-2:20 Break

2:20-3:45 Financing Trends and Market Overview

  • Royalty Monetization
  • Convertible Debt
  • Accounting Considerations
  • When should companies consider convertible debt?
  • Convertible structure in the life science financing cycle
  • Changes of control, tax implications, size, maturity and other questions

3:45-3:55 Break

3:55-4:50 IT General Controls

Agenda: DAY 2

8:45-9:55 Revenue Recognition: Evolving Issues - Life Sciences

  • Scope of Contract
  • Performance Obligations
  • Nature of promise: sales of points
  • Collaboration agreements
  • Sales using third party platforms
  • Gross vs Net
  • Counterparty Perspective

9:55-10:10 Break

10:10-11:30 Accounting for Financing Arrangements in Life Sciences

11:30-12:00 Break

12:00-1:30 Gross to Net

  • Introduction and Overview
  • Industry View
  • Estimation Methodology
  • Approaching Launch
  • Key Challenges
  • SEC Comments
  • Close and Financial Reporting
  • GTN Hot Topics Discussion
  • Inventory Accounting Refresh

1:30-1:40 Lunch Break

1:40-2:40 Tax Update

  • Latest legislative developments
  • Key Tax Proposals
  • Possible timing and other legislative priorities

2:40-2:55 Break

2:55-4:05 Accounting for R&D and Clinical Trials

  • R&D Funding Arrangements
  • R&D Cost Classifications
  • Other Intangible Assets
  • SEC Comment Letter Trends

4:05-4:15 Break

4:15-5:00 Value Based Care

  • Guarantees and indemnifications
  • Accounting challenges
  • Revenue Recognition components

CPE: Earn up to 16 credits

Speakers

  • Nathan Mitchell, Deloitte, Partner
  • Adam Barrow, Riveron, Senior Director
  • Nick Sanfilippo, Riveron, Director, Accounting Advisory & IPO
  • Ruchi Tiwari, Deloitte, Senior Manager
  • Ester Kutalchuk, Deloitte, Senior Consultant
  • Matt Norman, Deloitte, Manager
  • Russ Higgins, Connor Group, Partner
  • Travis Combs, Riveron, Managing Director
  • Marcus Lindner, Ernst & Young, Partner
  • Boyang Zhao, Riveron, Director, Accounting Advisory
  • Nathaniel Spedalieri, Ernst & Young, Senior Manager
  • Annie Wong, Ernst & Young, Assurance Senior Manager
  • Rucha Waghulde, Deloitte, Senior Consultant
  • Kyle Straub, PwC, Director
  • Moira Klinger, PwC, Director
  • Emma Nealis, PwC, Manager
  • Aleks Zabreyko, Connor Group, Managing Partner
  • Jeffrey Kummer, Deloitte, Director of Tax Policy
  • Joshua Areola, Ernst & Young, Assurance Senior Manager
  • Tim Geringer, Ernst & Young, Senior Manager
  • James Bowie, Ernst & Young, Managing Director, Technical Accounting Advisory Group
  • Spencer Moses, Ernst & Young, FAAS Manager
  • Tanner Schnitz, Ernst & Young, Technical Accounting Manager
  • James Bowie, Ernst & Young, Managing Director, Technical Accounting Advisory Group
  • Randa Ghantous, Connor Group, Partner
  • Matt Lepley, Connor Group, Partner

For more information about this conference visit https://www.researchandmarkets.com/r/mug542

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

GlobeNewswire

Recommended Reading